Oma Fertility

Oma Fertility specializes in innovative fertility treatments using advanced technology for individuals and couples experiencing fertility challenges. The company leverages AI and robotics to enhance fertility treatments. Its flagship product is Oma Sperm InSight, a technology that uses AI to identify the most promising sperm cells for in vitro fertilization (IVF) procedures. This technology aims to improve the success rates of IVF by allowing embryologists to make more informed decisions during the sperm selection process. This is also complemented by the proprietary AI microscope that provides enhanced imaging and analysis capabilities during the IVF process.

The company operates full-service fertility clinics that offer comprehensive fertility care and treatments. This includes top lab design and technologies brought in-house, along with services like intrauterine insemination (IUI) and IVF. As of April 2024, it had clinics in Atlanta, Georgia, and New York City.

Key customers and partnerships

In December 2022, Oma Fertility partnered with Alto Pharmacy to allow Oma's patients to access Alto's services, such as free same-day prescription delivery, cost-effective medications, and easy access to pharmacists seven days a week. This partnership also helped patients receive their prescriptions at the best price with on-demand support.

Funding and financials

In June 2022, the company raised USD 37.5 million consisting of USD 29 million in Series A funding led by JAZZ Venture Partners, Root Ventures, Mithril Capital, Global Asset Capital, and Free Solo Ventures, along with USD 8.5 million of debt financing from the Silicon Valley Bank. The proceeds were expected to be used to expand the company's US operation.